Staten Biotechnology B.V.
Records under this name other than patents Staten Biotechnology B.V. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 5 of 5 · Back to Staten Biotechnology B.V.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,248,041 | Anti-ApoC3 antibodies Lapsed on the fee record Ended Feb 15, 2026 · From the USPTO record | Lapsed on the fee record | Ended Feb 15, 2026 | From the USPTO record |
| US 11,248,042 | Polynucleotides encoding anti-ApoC3 antibodies Lapsed on the fee record Ended Feb 15, 2026 · From the USPTO record | Lapsed on the fee record | Ended Feb 15, 2026 | From the USPTO record |
| US 11,242,381 | Anti-ApoC3 antibodies and methods of use thereof Lapsed on the fee record Ended Feb 8, 2026 · From the USPTO record | Lapsed on the fee record | Ended Feb 8, 2026 | From the USPTO record |
| US 11,091,539 | Anti-ApoC3 antibodies and methods of use thereof Lapsed on the fee record Ended Aug 17, 2025 · From the USPTO record | Lapsed on the fee record | Ended Aug 17, 2025 | From the USPTO record |
| US 10,538,583 | Anti-APOC3 antibodies and compositions thereof Lapsed on the fee record Ended Jan 21, 2024 · From the USPTO record | Lapsed on the fee record | Ended Jan 21, 2024 | From the USPTO record |